Gene · 407039
Papers2,468
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 2,468
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated Genomics Identifies miR-181/TFAM Pathway as a Critical Driver of Drug Resistance in Melanoma. | Int J Mol Sci | 2021 | 33670365 | PubTator, text mining | PubMed |
| Long noncoding RNA LINC00518 induces radioresistance by regulating glycolysis through an miR-33a-3p/HIF-1α negative feedback loop in melanoma. | Cell Death Dis | 2021 | 33664256 | PubTator, text mining | PubMed |
| MicroRNA-33 Inhibits Adaptive Thermogenesis and Adipose Tissue Beiging. | Arterioscler Thromb Vasc Biol | 2021 | 33657886 | PubTator, text mining | PubMed |
| Integrated miRNA and mRNA omics reveal the anti-cancerous mechanism of Licochalcone B on Human Hepatoma Cell HepG2. | Food Chem Toxicol | 2021 | 33647349 | PubTator, text mining | PubMed |
| m6A RNA Methylation Regulators Act as Potential Prognostic Biomarkers in Lung Adenocarcinoma. | Front Genet | 2021 | 33643384 | PubTator, text mining | PubMed |
| Shared Genetic and Epigenetic Mechanisms between the Osteogenic Differentiation of Dental Pulp Stem Cells and Bone Marrow Stem Cells. | Biomed Res Int | 2021 | 33628811 | PubTator, text mining | PubMed |
| Functional and Therapeutic Relevance of Rho GTPases in Innate Immune Cell Migration and Function during Inflammation: An In Silico Perspective. | Mediators Inflamm | 2021 | 33628114 | PubTator, text mining | PubMed |
| microRNA-33 maintains adaptive thermogenesis via enhanced sympathetic nerve activity. | Nat Commun | 2021 | 33594062 | PubTator, text mining | PubMed |
| Circulating RNA biomarkers in diffuse large B-cell lymphoma: a systematic review. | Exp Hematol Oncol | 2021 | 33593440 | PubTator, text mining | PubMed |
| miR-33 Silencing Reprograms the Immune Cell Landscape in Atherosclerotic Plaques. | Circ Res | 2021 | 33593073 | PubTator, text mining | PubMed |
| JCL roundtable: Lipids and inflammation in atherosclerosis. | J Clin Lipidol | 2021 | 33589093 | PubTator, text mining | PubMed |
| Integrated analysis of differentially expressed genes and construction of a competing endogenous RNA network in human Huntington neural progenitor cells. | BMC Med Genomics | 2021 | 33579286 | PubTator, text mining | PubMed |
| MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review. | Cancers (Basel) | 2021 | 33572780 | PubTator, text mining | PubMed |
| The Emerging Role of TXNIP in Ischemic and Cardiovascular Diseases; A Novel Marker and Therapeutic Target. | Int J Mol Sci | 2021 | 33567593 | PubTator, text mining | PubMed |
| Asparanin A inhibits cell migration and invasion in human endometrial cancer via Ras/ERK/MAPK pathway. | Food Chem Toxicol | 2021 | 33561516 | PubTator, text mining | PubMed |
| Mechanistic role of DANCR in the choreography of signaling pathways in different cancers: Spotlight on regulation of Wnt/β-catenin and JAK/STAT pathways by oncogenic long non-coding RNA. | Noncoding RNA Res | 2021 | 33553855 | PubTator, text mining | PubMed |
| Dysregulation of serum miR-361-5p serves as a biomarker to predict disease onset and short-term prognosis in acute coronary syndrome patients. | BMC Cardiovasc Disord | 2021 | 33546604 | PubTator, text mining | PubMed |
| MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3'UTR. | Exp Hematol Oncol | 2021 | 33531067 | PubTator, text mining | PubMed |
| miRNA-Based Therapeutics in the Era of Immune-Checkpoint Inhibitors. | Pharmaceuticals (Basel) | 2021 | 33530393 | PubTator, text mining | PubMed |
| Recent advances and future avenues in understanding the role of adipose tissue cross talk in mediating skeletal muscle mass and function with ageing. | Geroscience | 2021 | 33528828 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407039/papers?page=47